News Search Results
Feb 27, 2025, 11:45 ET Dermal Fillers Market Size Worth $7.58 Billion, Globally, by 2031 Growing at 8.3% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 27, 2025, 11:30 ET Bacterial Vaginosis Drug Market to Surge to $3.82 Billion by 2031, Fuelled by Growing Awareness and Treatment Innovation | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 27, 2025, 11:15 ET DPCR & qPCR Market Size Worth 18.23 billion by 2030 | Growing 9.3% CAGR: Exclusive Report by The Insight Partners
amplification as the reaction proceeds. It is an extensively used diagnostic technique in diverse sectors such as research, pharmaceuticals, and biotechnology, offering a wide range of applications. qPCR technologies have experienced significant market growth due to their numerous advantages over traditional
More news about: The Insight Partners
Feb 27, 2025, 11:00 ET Dry Eye Products Market Size Worth 10.04 billion by 2030 | Growing at 4.7% CAGR: Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 27, 2025, 10:45 ET Biscuits and Cookies Market Size to Reach a Value of US$ 120.15 Billion by 2031, Growing at 4.1% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 27, 2025, 10:30 ET Frozen Bakery Products Market Size to Hit US$ 16.53 Billion by 2031, Driven by Growing Sales of Frozen Food Via E-Commerce Platforms
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 27, 2025, 10:04 ET Oncology Breakthroughs: How Cancer Research Is Advancing in 2025
industry developments and happenings in the market include: Back in December, Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology,
More news about: USA News Group
Feb 27, 2025, 10:00 ET Astellas and MBC BioLabs Announce the Sixth Annual Astellas Future Innovator Prize
companies, today announced their collaboration on the Astellas Future Innovator Prize. The competition offers entrepreneurial scientists and emerging biotechnology start-ups one year's priority usage of MBC BioLabs' state-of-the-art Bay Area facilities and access to Astellas' research and development capabilities
More news about: Astellas Pharma Inc.
Feb 27, 2025, 09:45 ET Anivive Sponsors 69th Annual Coccidioidomycosis Study Group Meeting
https://www.anivive.com/valley-fever About Anivive Lifesciences Anivive Lifesciences is a software-driven pet pharmaceutical company at the forefront of biotechnology, artificial intelligence, and veterinary medicine. Our mission is to transform veterinary healthcare by accelerating the development of novel, affordable
More news about: Anivive Lifesciences Inc.
Feb 27, 2025, 09:00 ET Hemab Therapeutics Announces Start of Velora Pioneer, a Phase 1/2 Clinical Trial Investigating HMB-002 for the Treatment of Von Willebrand Disease
Mass., Feb. 27, 2025 /PRNewswire/ -- Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders, today announced the first participant
More news about: Hemab Therapeutics
Feb 27, 2025, 08:00 ET Genesee Scientific Engages Channel Partnership Services to Further Enhance ProSci's Global Commercial Strategy
distributor of products to the global life science research markets. With thousands of products available, its markets include pharmaceutical and biotechnology companies, colleges, universities, and secondary education institutions, medical research institutions, hospitals and reference labs and quality
More news about: Genesee Scientific
Feb 27, 2025, 07:45 ET Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates
Feb. 27, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results for the three and twelve months ended December 31, 2024, and highlighted
More news about: Heron Therapeutics, Inc.
Feb 27, 2025, 07:00 ET NLS Pharmaceutics Announces New Preclinical Data for AEX-2, Expanding the Therapeutic Potential of its Non-Sulfonamide Dual Orexin Receptor Agonist Platform
Model," will be displayed on May 27-30, 2025. About Aexon Labs Aexon Labs is a cutting-edge biotechnology company specializing in intelligente drug discovery and computational chemistry to develop next-generation therapeutics for sleep disorders, neurodegenerative
More news about: NLS Pharmaceutics Ltd.
Feb 27, 2025, 07:00 ET On Growth Path for a Decade plus: Strong Launch Execution driving Company Growth
access to our medicines and achieved SBTi validation for our Net Zero Targets. Our efforts were recognized by Sustainalytics ranking UCB first in Biotechnology and the Carbon Disclosure Project with an A- for climate and water security." UCB's FY 2024 financial results
More news about: UCB
Feb 27, 2025, 06:30 ET Nuvalent Outlines Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2024 Financial Results
brings nearly four decades of proven leadership in building and growing biotechnology companies to the Nuvalent board. Throughout his career, he has served in senior leadership roles at several specialty pharmaceutical and biotechnology companies and worked alongside oncologists as part of the leadership
More news about: Nuvalent, Inc.
Feb 27, 2025, 05:45 ET Shareholders of ICON Public Limited Company Should Contact The Gross Law Firm Before April 11, 2025 to Discuss Your Rights - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: The Gross Law Firm
Feb 27, 2025, 04:25 ET India Sustainability Conclave 2025 Concludes with a Renewed Commitment to Accelerating Progress Towards Sustainable Development Goals
Research & Development, PDEU, Dr. Sachidanand Singh, Head-Department of Biotechnology, School of Energy Technology, PDEU, Dr. Pradeep P S, Assistant Professor, Biotechnology, PDEU, Megha Das, Founder, Amounee, Dr. Deepika
More news about: Springer Nature
Feb 26, 2025, 20:56 ET Robbins LLP Reminds ICON PLC (ICLR) Investors With Large Losses to Contact the Firm to Learn How They Can Recover for Their Losses
offerings were insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the RFPs ICON received from its biotechnology customers during the class period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Robbins LLP
Feb 26, 2025, 16:05 ET REGENXBIO to Host Conference Call on March 13 to Discuss Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
participating are advised to join 15 minutes prior to the start time. ABOUT REGENXBIO Inc.REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development
More news about: REGENXBIO Inc.
Feb 26, 2025, 13:36 ET IS4S Awarded Two OASIS+ Contracts: Total Small Business & Unrestricted
applied research, and experimental development. Services include conducting R&D in: the physical, engineering and life sciences, nanotechnology, biotechnology, and social sciences and humanities.Technical and Engineering Services Domain: This Domain includes requirements to provide specific
More news about: IS4S
Feb 26, 2025, 10:39 ET CRISPR Market is expected to generate a revenue of USD 12.78 Billion by 2032, Globally, at 15.85% CAGR: Verified Market Research®
rapid advancements, with applications spanning gene editing, agriculture, drug discovery, and personalized medicine. With increasing investments in biotechnology and life sciences, the market is expected to experience exponential growth in the coming years. Key Highlights of the Market Report:
More news about: Verified Market Research
Feb 26, 2025, 10:24 ET Bioactive Dressings Market is expected to generate a revenue of USD 7.99 Billion by 2032, Globally, at 10.7% CAGR: Verified Market Research®
Global Bioactive Materials Market Size By Application (Orthopedics, Dental Care, Nanomedicines & Biotechnology), By Type (Bioactive Glass, Bioactive Ceramics, Bioactive Composites), By End-User (Healthcare & Biomedical, Cosmetics & Personal Care, Food
More news about: Verified Market Research
Feb 26, 2025, 10:04 ET Antimicrobial Resistance Surveillance Market is expected to generate a revenue of USD 9.86 Billion by 2032, Globally, at 5.65% CAGR: Verified Market Research®
driving an increased demand for sophisticated diagnostic tools and real-time data analytics. This presents a profitable potential for pharmaceutical, biotechnology, and healthcare IT companies to produce advanced surveillance technologies, facilitating market growth. Advancements in AI-Driven Surveillance
More news about: Verified Market Research
Feb 26, 2025, 10:00 ET VIST Labs Announces Strategic Partnership with Paralab to Expand European Distribution of Cannabis Decontamination and Packaging Solutions
Paralab, based in Porto, Portugal, specializes in providing innovative equipment solutions for the pharmaceutical, biotechnology, chemical, and cannabis sectors. With over 30 years of industry leadership, Paralab combines technical expertise and exceptional customer support
More news about: VIST Labs, LLC
Feb 26, 2025, 09:30 ET Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company